🔊 Your guide to AI: May 2021
This week, we announced the acquisition of AI-first precision medicine leader Allcyte by Exscientia, a leading AI-first drug design company. Read more on why this is a big deal in my Twitter thread, which also marks the first exit for Air Street Capital.
See you in 3 weeks for the next issue of Your guide to AI: June 2021.
As always, thanks for hitting forward to a couple of friends 🙏
Nathan Benaich, 20 June 2021
Air Street Capital is a venture capital firm investing in AI-first technology and life science companies. We’re an experienced team of investors and founders based in Europe and the US with a shared passion for working with entrepreneurs from the very beginning of their company-building journey.